These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23110460)

  • 21. Aminoglycosides: Time for the Resurrection of a Neglected Class of Antibacterials?
    Böttger EC; Crich D
    ACS Infect Dis; 2020 Feb; 6(2):168-172. PubMed ID: 31855407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
    Rai R; Chen HN; Czyryca PG; Li J; Chang CW
    Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Di-N-Methylation of Anti-Gram-Positive Aminoglycoside-Derived Membrane Disruptors Improves Antimicrobial Potency and Broadens Spectrum to Gram-Negative Bacteria.
    Benhamou RI; Shaul P; Herzog IM; Fridman M
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13617-21. PubMed ID: 26418734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria.
    Khan F; Pham DTN; Kim YM
    Appl Microbiol Biotechnol; 2020 Mar; 104(5):1955-1976. PubMed ID: 31970432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular insights into aminoglycoside action and resistance.
    Magnet S; Blanchard JS
    Chem Rev; 2005 Feb; 105(2):477-98. PubMed ID: 15700953
    [No Abstract]   [Full Text] [Related]  

  • 26. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiating aminoglycoside antibiotics to reduce their toxic side effects.
    Rosenberg CR; Fang X; Allison KR
    PLoS One; 2020; 15(9):e0237948. PubMed ID: 32877437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenolic compounds and interaction between aminoglycosides and natural products of Lygodium venustum SW against multiresistant bacteria.
    Morais-Braga MF; Souza TM; Santos KK; Guedes GM; Andrade JC; Tintino SR; Sobral-Souza CE; Costa JG; Saraiva AA; Coutinho HD
    Chemotherapy; 2012; 58(5):337-40. PubMed ID: 23171666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between the structure and toxicity of aminoglycoside antibiotics.
    Jospe-Kaufman M; Siomin L; Fridman M
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127218. PubMed ID: 32360102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
    Bragonzi A
    Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.
    Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T
    Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial resistance to aminoglycoside antibiotics.
    Davies J; Wright GD
    Trends Microbiol; 1997 Jun; 5(6):234-40. PubMed ID: 9211644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel hygromycin A antibacterial agents.
    Visser MS; Freeman-Cook KD; Brickner SJ; Brighty KE; Le PT; Wade SK; Monahan R; Martinelli GJ; Blair KT; Moore DE
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6730-4. PubMed ID: 20864341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the regioselectivity for the staudinger reaction and its application for the synthesis of aminoglycosides with N-1 modification.
    Li J; Chiang FI; Chen HN; Chang CW
    J Org Chem; 2007 May; 72(11):4055-66. PubMed ID: 17465564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minor components of aminoglycosides: recent advances in their biosynthesis and therapeutic potential.
    Ban YH; Song MC; Park JW; Yoon YJ
    Nat Prod Rep; 2020 Mar; 37(3):301-311. PubMed ID: 31501843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of aminoglycoside antibiotics by carbohydrate chemistry.
    Guo L; Wan Y; Wang X; Wang PG; Zhao W
    Mini Rev Med Chem; 2012 Dec; 12(14):1533-41. PubMed ID: 22827181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside microarrays to study antibiotic resistance.
    Disney MD; Magnet S; Blanchard JS; Seeberger PH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1591-4. PubMed ID: 15022242
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Han ZQ; Hao XY; Han J; Li ZS; Wang GC
    Phytomedicine; 2014 Jun; 21(7):936-41. PubMed ID: 24703330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.